G2B BioSolutions ApS
CVR 42437069 · Private limited company (ApS) · Active · Low risk
G2B BioSolutions ApS is a Private limited company (ApS), founded on , based in Hellerup. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.5% over the next 12 months, which is 0.4 times the average for Danish companies. 5 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK -1.2m and a net result of DKK 137k. CEO: Dayanand Suryabhan Jadhav.
Bankruptcy risk for G2B BioSolutions ApS
0.4 × the average (1.41%) · higher risk than 60% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 42437069
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (5 years)
- Address
- Hagens Alle 7
2900 Hellerup - Municipality
- Gentofte
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 40k
- Auditor
- Crowe
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 1 of 5 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -191.2% |
| Current ratio | 26% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 1 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 8 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 45k | DKK 436k | DKK -741k |
| Net profit | DKK 137k | DKK 371k | DKK -1.5m |
| Equity | DKK -1.2m | DKK -1.4m | DKK -1.7m |
| Total assets | DKK 635k | DKK 592k | DKK 90k |
| Cash | DKK 88k | DKK 257k | – |
| Short-term debt | DKK 1.1m | DKK 1.1m | – |
| Avg. employees | 0 | 1 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Crowe.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 135 | ||
| 1 Jan 2024 – 31 Dec 2024 | 154 | ||
| 1 Jan 2023 – 31 Dec 2023 | 102 | ||
| 1 Jan 2022 – 31 Dec 2022 | 159 | ||
| 3 Jun 2021 – 31 Dec 2021 | 194 | Late |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Dayanand Suryabhan Jadhav | Current | |
| CEO | Prashant Madhusudan Bapat | ||
| Owner (100%) | Dayanand Jadhav Holding ApS | Current | |
| Owner (50%) | Dayanand Suryabhan Jadhav | ||
| Owner (50%) | Prashant Madhusudan Bapat | ||
| Owner (100%) | Dayanand Suryabhan Jadhav | ||
| Founder | Dayanand Suryabhan Jadhav | Current | |
| Founder | Prashant Madhusudan Bapat | Current |
The CEOs' other companies
Dayanand Suryabhan Jadhav – 4 other companies
- Dayanand Jadhav Holding ApS Active
- G2B BioSolutions Denmark ApS Opløst
- SNL BioSolutions ApS Active
- SNLB Holding ApS Active
Prashant Madhusudan Bapat – 1 other companies
- Prashan Bapat Holding ApS Active
Address history (0 moves)
| Hagens Alle 7, 2900 Hellerup |
Other companies at the same address
- A.C. BENDIXEN BILER ApS Opløst
- Dayanand Jadhav Holding ApS Active
- G2B BioSolutions Denmark ApS Opløst
- M B EJENDOMME ApS Opløst
- M B INVEST ApS Opløst
- NORDKYSTENS IMPORT ApS Opløst
- SNL BioSolutions ApS Active
- SNLB Holding ApS Active
Similar companies in Gentofte
- SNL BioSolutions ApS Hellerup
- NIVI Development A/S Hellerup
- Neo Biopharm ApS Hellerup
- Beatsco2 ApS Charlottenlund
- MHJ Research ApS Hellerup
- XY Therapeutics ApS Charlottenlund
- Lophora ApS Charlottenlund
- CABA APS Charlottenlund
- Devopharma ApS Charlottenlund
- C- ApS Hellerup
- UNION therapeutics A/S Hellerup
- Aktieselskabet af 1. juni 2011 II Hellerup
Questions and answers about G2B BioSolutions ApS
Has G2B BioSolutions ApS gone bankrupt?
No, G2B BioSolutions ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of G2B BioSolutions ApS?
Our model estimates a bankruptcy risk of 0.5% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.
Who is the CEO of G2B BioSolutions ApS?
Dayanand Suryabhan Jadhav is the CEO of G2B BioSolutions ApS.
Who is the auditor of G2B BioSolutions ApS?
G2B BioSolutions ApS most recently used Crowe.
When was G2B BioSolutions ApS founded?
G2B BioSolutions ApS was founded on 3 June 2021.
What is the equity of G2B BioSolutions ApS?
Equity was DKK -1.2m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.